Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
A 30-Year Trend of Ischemic Heart Disease Burden in a Developing Country; a Systematic Analysis of the Global Burden of Disease Study 2019 in Iran Publisher Pubmed



Koolaji S1 ; Sharifnejad Tehrani Y1 ; Azadnajafabad S1 ; Saeedi Moghaddam S1 ; Shahin S1 ; Ghamari A1 ; Ahmadi N1 ; Rezaei N1, 2 ; Keykhaei M3 ; Tavolinejad H1 ; Ghamari SH1 ; Abbasikangevari M1 ; Rezaei N1, 2 ; Larijani B2 Show All Authors
Authors
  1. Koolaji S1
  2. Sharifnejad Tehrani Y1
  3. Azadnajafabad S1
  4. Saeedi Moghaddam S1
  5. Shahin S1
  6. Ghamari A1
  7. Ahmadi N1
  8. Rezaei N1, 2
  9. Keykhaei M3
  10. Tavolinejad H1
  11. Ghamari SH1
  12. Abbasikangevari M1
  13. Rezaei N1, 2
  14. Larijani B2
  15. Farzadfar F1, 2
Show Affiliations
Authors Affiliations
  1. 1. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Feinberg Cardiovascular and Renal Research Institute, Northwestern University School of Medicine, Chicago, United States

Source: International Journal of Cardiology Published:2023


Abstract

Background: Evaluating the burden of ischemic heart disease (IHD) as the first cause of mortality worldwide is necessary to develop healthcare policies. This study aimed to report the national and subnational IHD burden and risk factors in Iran according to the Global Burden of Disease (GBD) study 2019. Methods: We extracted, processed, and presented the results of the GBD 2019 study regarding incidence, prevalence, deaths, years lived with disability (YLDs), years of life lost (YLLs), disability-adjusted life years (DALYs), and attributable burden to risk factors of IHD in Iran during 1990–2019. Results: Age-standardized death and DALY rates decreased by 42.7% (95% uncertainty interval, 38.1–47.9) and 47.7% (43.6–52.9) during 1990–2019, slower since 2011 and reached 163.6 deaths (149.0–176.2), 2842.7 DALYs (2657.0–3103.1) per 100,000 persons in 2019. Meanwhile, with a lower reduction of 7.7% (6.0–9.5), the incidence rate reached 829.1 new cases (719.9–945.2) per 100,000 persons in 2019. High systolic blood pressure and elevated low-density lipoprotein cholesterol (LDL-C) contributed to the highest deaths, and DALYs age-standardized rates in 1990 and 2019. They followed by high fasting plasma glucose (FPG), and high body-mass index (BMI) with an upward trend of contribution from 1990 to 2019. A convergence pattern in the provincial death age-standardized rate was observed, with the lowest rate in Iran's capital city; 84.7 deaths per 100,000 (70.6–99.4) in 2019. Conclusion: The incidence rate reduced remarkably lower than the mortality rate, which necessitates promoting primary prevention strategies. Also, interventions should be adopted to control growing risk factors like high FPG, and high BMI. © 2023 Elsevier B.V.
Related Docs
View other Related Docs
1. Metabolic Risk Factors Attributed Burden in Iran at National and Subnational Levels, 1990 to 2019, Frontiers in Public Health (2023)
2. Non-Communicable Diseases’ Risk Factors in Iran; a Review of the Present Status and Action Plans, Journal of Diabetes and Metabolic Disorders (2021)
3. Burden of Ischemic Heart Disease and Its Attributable Risk Factors in North Africa and the Middle East, 1990 to 2019: Results From the Gbd Study 2019, Journal of the American Heart Association (2024)
4. Evaluation of the Diabetes Care Cascade and Compliance With Who Global Coverage Targets in Iran Based on Steps Survey 2021, Scientific Reports (2023)
5. National and Subnational Burden of Stroke in Iran From 1990 to 2019, Annals of Clinical and Translational Neurology (2022)
6. Temporal Trends in Cardiovascular Disease Risk Factors Attributed Burden in Iran, 1990–2021, Scientific Reports (2025)
7. The Levels and Trends of Metabolic Risk Factors in the Elderly Population at the National and Sub-National Scale in Iran From 1990 to 2016, Journal of Diabetes and Metabolic Disorders (2023)
8. Estimating the Burden of Atrial Fibrillation and Atrial Flutter With Projection to 2050 in Iran, Scientific Reports (2024)
Experts (# of related papers)
View all Related Experts
Farshad Farzadfar (68)
Bagher Larijani (62)
Other Related Docs
9. National and Sub-National Burden and Trend of Type 1 Diabetes in 31 Provinces of Iran, 1990–2019, Scientific Reports (2023)
10. Prevalence of Plasma Lipid Abnormalities and Associated Risk Factors Among Iranian Adults Based on the Findings From Steps Survey 2021, Scientific Reports (2023)
11. National and Subnational Survey on Diabetes Burden and Quality of Care Index in Iran: A Systematic Analysis of the Global Burden of Disease Study 1990–2019, Journal of Diabetes and Metabolic Disorders (2022)
12. Mortality and Disability-Adjusted Life Years in North Africa and Middle East Attributed to Kidney Dysfunction: A Systematic Analysis for the Global Burden of Disease Study 2019, Clinical Kidney Journal (2024)
13. Burden of Road Traffic Injuries in Iran: A National and Subnational Perspective, 1990-2019, Injury Prevention (2023)
14. Epidemiology, Burden, and Attributable Risks of Infective Endocarditis in Iran and Its Provinces: From 1990 to 2019, International Journal of Cardiology (2022)
15. The First Nationally and Sub-Nationally Representative Non-Communicable Diseases Cohort Study in Iran: Iran Cohort Study (Ics) Protocol, Journal of Diabetes and Metabolic Disorders (2023)
16. Importance of Population-Wide Studies in Controlling Noncommunicable Diseases: Achievements of Non-Communicable Diseases Research Center, Endocrinology and Metabolism Research Institute, Iranian Journal of Diabetes and Metabolism (2021)
17. Prevalence of Diabetes and Prediabetes, and Achievements in Diabetes Control in Iran; the Results of the Steps of 2016, Archives of Iranian Medicine (2022)
18. The Effect of Real-Time Feedback and Incentives on Speeding Behaviors Using Telematics: A Randomized Controlled Trial, Accident Analysis and Prevention (2023)
19. Protocol Design for Large-Scale Cross-Sectional Studies of Surveillance of Risk Factors of Non-Communicable Diseases in Iran: Steps 2016, Archives of Iranian Medicine (2017)
20. National, Subnational and Risk Attributed Burden of Chronic Respiratory Diseases in Iran From 1990 to 2019, Respiratory Research (2023)
21. Low Bone Mineral Density, a Neglected Condition in North Africa and Middle East: Estimates From the Global Burden of Disease Study, 1990–2019, Osteoporosis International (2023)
22. Burden of Ischemic Heart Disease and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019, European Journal of Preventive Cardiology (2022)
23. Rheumatic Heart Disease Is a Neglected Disease Relative to Its Burden Worldwide: Findings From Global Burden of Disease 2019, Journal of the American Heart Association (2022)
24. The Burden of Metabolic Risk Factors in North Africa and the Middle East, 1990–2019: Findings From the Global Burden of Disease Study, eClinicalMedicine (2023)
25. Global, Regional, and National Burden of Diabetes From 1990 to 2021, With Projections of Prevalence to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2023)
26. “Current Incidence of Injuries in Iran; Findings of Steps Survey 2021”, Heliyon (2023)
27. Burden of Non-Communicable Diseases in Iran: Past, Present, and Future, Journal of Diabetes and Metabolic Disorders (2020)
28. Ottawa Charter Framework As a Guide for Type 2 Diabetes Prevention and Control in Iran, Journal of Diabetes and Metabolic Disorders (2019)
29. The Burden of Rheumatoid Arthritis and Low Back Pain in North Africa and Middle East From 1990 to 2019: Results From the Global Burden of Disease Study 2019, International Journal of Rheumatic Diseases (2023)
30. Trends of National and Sub-National Burden Attributed to Kidney Dysfunction Risk Factor in Iran: 1990-2019, Frontiers in Endocrinology (2023)
31. Incident Type 2 Diabetes Attributable to Suboptimal Diet in 184 Countries, Nature Medicine (2023)
32. Global Incidence, Prevalence, Years Lived With Disability (Ylds), Disability-Adjusted Life-Years (Dalys), and Healthy Life Expectancy (Hale) for 371 Diseases and Injuries in 204 Countries and Territories and 811 Subnational Locations, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet (2024)
33. Trend and Projection of Non-Communicable Diseases Risk Factors in Iran From 2001 to 2030, Scientific Reports (2024)
34. The Burden of Neck Pain Among Adults Aged 70 Years and Older in Iran, 1990–2019, Health Science Reports (2023)
35. Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990–2021: A Systematic Analysis for the Global Burden of Disease Study 2021, The Lancet Neurology (2024)
36. The Contribution of Metabolic Risk Factors to Cardiovascular Mortality in Golestan Cohort Study: Population Attributable Fraction Estimation, International Journal of Cardiology: Cardiovascular Risk and Prevention (2024)
37. Risk of Incident Cardiovascular Diseases at National and Subnational Levels in Iran From 2000 to 2016 and Projection Through 2030: Insights From Iran Steps Surveys, PLoS ONE (2023)
38. Prevalence and Trends of Coronary Artery Disease Risk Factors and Their Effect on Age of Diagnosis in Patients With Established Coronary Artery Disease: Tehran Heart Center (2005–2015), BMC Cardiovascular Disorders (2021)
39. Injury Burden in Individuals Aged 50 Years or Older in the Eastern Mediterranean Region, 1990–2019: A Systematic Analysis From the Global Burden of Disease Study 2019, The Lancet Healthy Longevity (2022)
40. Prevalence and Determinants of Diabetes and Prediabetes in Southwestern Iran: The Khuzestan Comprehensive Health Study (Kchs), BMC Endocrine Disorders (2021)
41. Quality of Care of Peptic Ulcer Disease Worldwide: A Systematic Analysis for the Global Burden of Disease Study 1990-2019, PLoS ONE (2022)
42. Population Attributable Fraction Estimates of Cardiovascular Diseases in Different Blood Pressure Levels in a Large-Scale Cross-Sectional Study: A Focus on Prevention Strategies and Treatment Coverage, Blood Pressure Monitoring (2023)
43. Prevalence, Awareness, Treatment and Control of Diabetes Among Iranian Population: Results of Four National Cross-Sectional Stepwise Approach to Surveillance Surveys, BMC Public Health (2022)
44. Particulate Matter Pollution Remains a Threat for Cardiovascular Health: Findings From the Global Burden of Disease 2019, Journal of the American Heart Association (2023)
45. Physical Activity Pattern in Iran: Findings From Steps 2021, Frontiers in Public Health (2023)
46. Attributable Disease Burden Related to Low Bone Mineral Density in Iran From 1990 to 2019: Results From the Global Burden of Disease 2019, Archives of Osteoporosis (2022)
47. National, Sub-National, and Risk-Attributed Burden of Thyroid Cancer in Iran From 1990 to 2019, Scientific Reports (2022)
48. Cohort Profile: The Persian Dena Cohort Study (Pdcs) of Non-Communicable Diseases in Southwest Iran, BMJ Open (2024)
49. A Machine Learning Approach to Evaluate the State of Hypertension Care Coverage: From 2016 Steps Survey in Iran, PLoS ONE (2022)
50. National and Subnational Burden of Female and Male Breast Cancer and Risk Factors in Iran From 1990 to 2019: Results From the Global Burden of Disease Study 2019, Breast Cancer Research (2023)